However, despite this evidence for mis-splicing in the SMA disease pathway, other studies have suggested that wide-spread splicing defects mainly occur during the late stage of the disease [101], supporting the theory that alternative roles of SMN may play an equally important part in cell function. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.